C.J. Bol

681 total citations
10 papers, 557 citations indexed

About

C.J. Bol is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, C.J. Bol has authored 10 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in C.J. Bol's work include Drug Transport and Resistance Mechanisms (3 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer Treatment and Pharmacology (3 papers). C.J. Bol is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer Treatment and Pharmacology (3 papers). C.J. Bol collaborates with scholars based in Netherlands, United States and Belgium. C.J. Bol's co-authors include Peter Palmer, R. Woestenborghs, Ate van der Gaast, Lia van Zuylen, Alex Sparreboom, Jaap Verweij, C. Chow, R. B. Nussenblatt, Charles L. Bowden and Vladimir Piotrovsky and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and American Heart Journal.

In The Last Decade

C.J. Bol

9 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C.J. Bol Netherlands	8	391	271	87	61	54	10	557
Greta Cipriani Italy	7	325 0.8×	166 0.6×	87 1.0×	91 1.5×	114 2.1×	7	529
Maria A.J. van Eijndhoven Netherlands	7	356 0.9×	258 1.0×	73 0.8×	26 0.4×	77 1.4×	8	520
Ronald Drengler United States	13	487 1.2×	296 1.1×	104 1.2×	16 0.3×	68 1.3×	27	701
Olga Ujhelly Hungary	10	514 1.3×	400 1.5×	110 1.3×	95 1.6×	113 2.1×	15	759
Seiji Doi Japan	12	511 1.3×	365 1.3×	177 2.0×	25 0.4×	78 1.4×	20	737
Lyn M. Huff United States	15	366 0.9×	305 1.1×	78 0.9×	21 0.3×	90 1.7×	18	570
Benjamin F. Chu United States	8	241 0.6×	209 0.8×	62 0.7×	68 1.1×	52 1.0×	8	517
Valerie D. Doodeman Netherlands	11	424 1.1×	295 1.1×	113 1.3×	29 0.5×	39 0.7×	12	632
Joanna Regis United States	10	550 1.4×	270 1.0×	47 0.5×	26 0.4×	160 3.0×	14	660
J. H. M. Schellens Netherlands	12	281 0.7×	156 0.6×	83 1.0×	29 0.5×	21 0.4×	18	506

Countries citing papers authored by C.J. Bol

Since Specialization

Citations

This map shows the geographic impact of C.J. Bol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.J. Bol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.J. Bol more than expected).

Fields of papers citing papers by C.J. Bol

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.J. Bol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.J. Bol. The network helps show where C.J. Bol may publish in the future.

Co-authorship network of co-authors of C.J. Bol

This figure shows the co-authorship network connecting the top 25 collaborators of C.J. Bol. A scholar is included among the top collaborators of C.J. Bol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.J. Bol. C.J. Bol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Wang, Qing, Poornima Sood, C.J. Bol, et al.. (2009). Pharmacokinetic Sub‐Study in the SPIRIT III Randomized and Controlled Trial of XIENCE V^® Everolimus Eluting Coronary Stent System. Journal of Interventional Cardiology. 23(1). 26–32. 10 indexed citations

Wiemer, Marcus, Ashok Seth, Praveen Chandra, et al.. (2008). Systemic exposure of everolimus after stent implantation: A pharmacokinetic study. American Heart Journal. 156(4). 751.e1–751.e7. 16 indexed citations

Crul, Mirjam, G.J.M. de Klerk, Louis M. Weiner, et al.. (2002). Evaluation of the bioequivalence of tablets and capsules containing the novel anticancer agent R115777 (Zarnestra) in patients with advanced solid tumors. European Journal of Drug Metabolism and Pharmacokinetics. 27(1). 61–65. 8 indexed citations

Zuylen, Lia van, Alex Sparreboom, Ate van der Gaast, et al.. (2002). Disposition of docetaxel in the presence of P-glycoprotein inhibition by intravenous administration of R101933. European Journal of Cancer. 38(8). 1090–1099. 55 indexed citations

Crul, Mirjam, G.J.M. de Klerk, Laura J. van’t Veer, et al.. (2002). Phase I Clinical and Pharmacologic Study of Chronic Oral Administration of the Farnesyl Protein Transferase Inhibitor R115777 in Advanced Cancer. Journal of Clinical Oncology. 20(11). 2726–2735. 110 indexed citations

Punt, Cornelis J. A., et al.. (2001). Phase I and pharmacokinetic study of the orally administered farnesyl transferase inhibitor R115777 in patients with advanced solid tumors. Anti-Cancer Drugs. 12(3). 193–197. 55 indexed citations

Zuylen, Lia van, Alex Sparreboom, Ate van der Gaast, et al.. (2000). The orally administered P-glycoprotein inhibitor R101933 does not alter the plasma pharmacokinetics of docetaxel.. PubMed. 6(4). 1365–71. 84 indexed citations

Zujewski, J., Ivan D. Horak, C.J. Bol, et al.. (2000). Phase I and Pharmacokinetic Study of Farnesyl Protein Transferase Inhibitor R115777 in Advanced Cancer. Journal of Clinical Oncology. 18(4). 927–927. 218 indexed citations

Punt, C.J.A., Mary Linton B. Peters, C.J. Bol, et al.. (1999). Phase I trial with farnesyltransferase inhibitor R115777 in patients (pts) with advanced solid tumors. European Journal of Cancer. 35. S291–S291. 1 indexed citations

10.

Bol, C.J., et al.. (1987). Does chelidonium 3x lower serum cholesterol?. British Homeopathic journal. 76(1). 14–15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact